Approval · Notice of Compliance 23519 · 2020
RIXIMYO: Notice of Compliance 23519
Issued April 28, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23519
- Date
- April 28, 2020
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- RITUXAN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RIXIMYO | 02498316 | Marketed |